Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions

Annals of the New York Academy of Sciences

Volumn 814, Issue , 1997, Pages 125-141

  Rostene, William ^a   Azzi, Mounia ^a   Boudin, Helene ^a   Lepee, Isabelle ^a   Souaze, Frederique ^a   Mendez Ubach, Milagros ^a   Betancur, Catalina ^a   Gully, Danielle ^b  

^a HÔPITAL SAINT ANTOINE   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; BRAIN PROTEIN; BRAIN RECEPTOR; DOPAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; L 734836; LEVOCABASTINE; NEUROMEDIN N; NEUROTENSIN; NEUROTENSIN RECEPTOR; OPIATE ANTAGONIST; PD 156425; RECEPTOR SUBTYPE; SR 48527; SR 49711; UK 73093; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CENTRAL NERVOUS SYSTEM; CHEMICAL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EMBRYO DEVELOPMENT; IN VITRO STUDY; IN VIVO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROMODULATION; NONHUMAN; ONTOGENY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0030986240     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1997.tb46151.x     Document Type: Conference Paper

References (83)

1. CARRRAWAY, R. & S. E. LEEMAN. 1973. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. Biol. Chem. 248: 6854-6861.
2. EMSON, P. C., M. GOEDERT & P. W. MANTYH. 1985. Neurotensin-containing neurons. In Handbook of Chemical Neuroanatomy. GABA and Neuropeptides in the CNS. Vol. 4. A. Björklund & T. Hökfelt, Eds.: 355-405. Elsevier. Amsterdam.
3. MAI, J., K. J. TRIEPEL & J. METZ. 1987. Neurotensin in the human brain. Neuroscience 22: 499-524.
4. KITABGI, P. & C. B. NEMEROFF, Eds. 1992. The Neurobiology of Neurotensin. Ann. N. Y. Acad. Sci. 668: 1-374.
5. ROSTENE, W., A. BROUARD, C. DANA, Y. MASUO, F. AGID, M. VIAL, A. M. LHIAUBET & D. PELAPRAT. 1992. Interaction between neurotensin and dopamine in the brain. Morphological and clinical evidence. Ann. N. Y. Acad. Sci. 668: 217-231.
6. ERVIN, G. N. & C. B. NEMEROFF. 1988. Interactions of neurotensin with dopamine-containing neurons in the central nervous system. Neuropsychopharmacol. Biol. Psychiatry 12: S53-S69.
7. GARVER, D. L., G. BISSETTE, J. K. YAO & C. B. NEMEROFF. 1992. Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients. Am. J. Psychiatry 148: 484-488.
8. WIDERLÖV, E., L. H. LINDSTRÖM, G. BESEV, P. J. MANBERG, C. B. NEMEROFF, G. R. BREESE, J. S. KISER & A. J. PRANGE, JR. 1982. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: Normalization after neuroleptic treatment. Am. J. Psychiatry 139: 1122-1126.
9. KITABGI, P., F. CHECLER, J. MAZELLA & J. P. VINCENT. 1985. Pharmacology and biochemistry of neurotensin receptors. Rev. Clin. Basic Pharmacol. 5: 397-486.
10. DOBNER, P. R., D. L. BARBER, L. VILLA-KOMAROFF & C. MCKIERNAN. 1987. Cloning and sequence analysis of cDNA for the canine neurotensin/neuromedin N precursor. Proc. Natl. Acad. Sci. USA 84: 3516-3520.
11. HARA, Y., S. SHIOSAKA, E. SENBA, M. SAKANAKA, S. INAGAKI, H. TAKAGI, Y. KAWAI, K. TAKATSUKI, T. MATSUZAKI & M. TOHYAMA. 1982. Ontogeny of the neurotensin-containing neuron system of the rat: Immunohistochemical analysis. I. Forebrain and diencephalon. J. Comp. Neurol. 208: 177-195.
12. KIYAMA, H., M. SATO & P. C. EMSON. 1992. Ontogeny of neurotensin immunoreactivity and mRNA in the rat central nervous system. In Handbook of Chemical Neuroanatomy. Ontogeny of Transmitters and Peptides in the CNS. Vol. 10. A. Björklund, T. Hökfelt & M. Tohyama, Eds.: 399-430. Elsevier. Amsterdam.
13. SATO, M., H. KIYAMA, S. YOSHIDA, T. SAIKA & M. TOHYAMA. 1991. Postnatal ontogeny of cells expressing prepro-neurotensin/neuromedin N mRNA in the rat forebrain and midbrain: A hybridization histochemical study involving isotope-labeled and enzyme-labeled probes. J. Comp. Neurol. 310: 300-315.
14. NICOT, A., A. BEROD & W. ROSTENE. 1992. Distribution of prepro-neurotensin/neuromedin N mRNA in the young and adult rat forebrain. Ann. N. Y. Acad. Sci. 668: 361-364.
15. MAILLEUX, P. & J. J. VANDERHAEGEN. 1988. Transient neurotensin in the human inferior olive during development. Brain Res. 456: 199-203.
16. SAKAMOTO, N., J. P. MICHEL, N. KOPP & J. PEARSON. 1987. Neurotensin like immunoreactive neurons in the human infant diencephalon. Brain Res. 403: 31-42.
17. NEMEROFF, C. B. 1980. Neurotensin: Perhaps an endogenous neuroleptic. Biol. Psychiatry 15: 283-302.
18. DUBUC, I., J. COSTENTIN, J. P. TERRANOVA, M. C. BARNOUIN, P. SOUBRIE, G. LE FUR, w. ROSTENE & P. KITABGI. 1994. The nonpeptide neurotensin antagonist SR 48692 as a tool reveal putative neurotensin receptor subtypes. Br. J. Pharmacol. 112: 352-354.
19. JOLICOEUR, F. B., S. ST-PIERRE, C. AUBE, R. RIVEST & M. A. GAGNE. 1984. Relationships between structure and duration of neurotensin's central action: Emergence of long acting analogs. Neuropeptides 4: 467-476.
20. JOLICOEUR, F. B., M. A. GAGNE, R. RIVEST, A. DRUMHELLER & S. ST-PIERRE. 1993. Atypical neuroleptic-like behavioral effects of neurotensin. Brain Res. Bull. 32: 487-491.
21. ERVIN, G. N., C. B. NEMEROFF & A. J. PRANGE. 1981. Neurotensin blocks certain amphetamine-induced behaviours. Nature 291: 73-76.
22. KALIVAS, P. W., S. K. BURGESS, C. B. NEMEROFF & A. J. PRANGE. 1993. Behavioural and neurochemical effects of neurotensin microinjection into the ventral tegmental area of the rat. Neuroscience 8: 495-505.
23. NOUEL, D. & J. COSTENTIN. 1991. Inhibition of apomorphine-induced yawning and penile erection by neurotensin. Peptides 12: 755-759.
24. KILTS, C. D., C. M. ANDERSON, G. BISSETTE, T. D. ELY & C. B. NEMEROFF. 1988. Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei. Biochem. Pharmacol. 37: 1547-1554.
25. MERCHANT, K. M., D. J. DOBIE, F. M. FILLOUX, M. TOTZKE, M. ARAVAGIRI & D. M. DORSA. 1994. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions. J. Pharmacol. Exp. Ther. 27: 460-471.
26. MERCHANT, K. M. 1994. c-fos Antisense oligonucleotide specifically attenuates haloperidol-induces increases in neurotensin/neuromedin N mRNA expression in rat dorsal striatum. Mol. Cell. Neurosci. 5: 336-344.
27. SADOUL, J. L., P. KITABGI, W. ROSTENE, F. JAVOY-AGID & J. P. VINCENT. 1984. Characterization and visualization of neurotensin binding to receptor sites in human brain. Biochem. Biophys. Res. Commun. 120: 206-213.
28. 3-neurotensin. Neuroscience 22: 525-536.
29. PALACIOS, J. M. & M. J. KUHAR. 1981. Neurotensin receptors are located on dopamine-containing neurons in the rat midbrain. Nature 294: 587-589.
30. Brain Res. 1988. 457: 212-218.
31. QUIRION, R., C. CHIUEH, H. EVERIST & A. PERT. 1985. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals. Brain Res. 327: 385-389.
32. SCHOTTE, A., W. ROSTENE & P.M. LADURON. 1988. Different subcellular localization of neurotensin receptor and neurotensin acceptor sites in the rat brain dopaminergic system. J. Neurochem. 50: 1026-1033.
33. KITABGI, P., W. ROSTENE, M. DUSSAILLANT, A. SCHOTTE, P. M. LADURON & J. P. VINCENT. 1987. Two populations of neurotensin binding sites in murine brain: Discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur. J. Pharmacol. 140: 285-293.
34. ROSTENE, W. & M. ALEXANDER. 1996. Neurotensin involvement in neuroendocrine regulation. Front. Neuroendocrinol. In press.
35. PALACIOS, J. M., A. PAZOS, M. M. DIETL, M. SCHLUMPF & W. LICHTENSTEIGER. 1988. The ontogeny of brain neurotensin receptors studied by autoradiography. Neuroscience 25: 307-317.
36. HERMANS, E., A. JEANJEAN, P. LADURON, J. N. OCTAVE & J. M. MALOTEAUX. 1993. Postnatal ontogeny of the rat brain neurotensin receptor mRNA. Neurosci. Lett. 157: 45-48.
37. 3H] neurotensin binding sites in rat brain. Brain Res. 408: 326-328.
38. TANAKA, K., M. MASU & S. NAKANISHI. 1990. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4: 847-854.
39. OURY-DONAT, F., O. THURNEYSSEN, N. GONALONS, P. FORGEZ, D. GULLY, G. LE FUR & P. SOUBRIE. 1995. Characterization of the effect of SR48692 on inositol monophosphate, cyclic GMP and cyclic AMP responses linked to neurotensin receptor activation in neuronal and non-neuronal cells. Br. J. Pharmacol. 116: 1899-1905.
40. VITA, N., P. LAURENT, S. LEFORT, P. CHALON, X. DUMONT, M. KAGHAD, D. GULLY, G. LE FUR, P. FERRARA & D. CAPUT. 1993. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 317: 139-142.
41. WATSON, M., P. J. ISACKSON, M. MAKKER, M. S. YAMADA, M. YAMADA, B. CUSACK & E. RICHELSON. 1993. Identification of a polymorphism in the human neurotensin receptor gene. Mayo Clin. Proc. 68: 1043-1048.
42. BOUDIN, H., J. LABRECQUE, A. M. LHIAUBET. M. DENNIS, W. ROSTENE & D. PELAPRAT. 1996. Pharmacological and molecular characterization of the neurotensin receptor expressed in Sf9 cells. Biochem. Pharmacol. 51: 1243-1246.
43. SATO, M., H. KIYAMA & M. TOHYAMA. 1992. Different postnatal development of cells expressing mRNA encoding neurotensin receptor. Neuroscience 48: 137-149.
44. NICOT, A., W. ROSTENE & A. BEROD. 1994. Neurotensin receptor expression in the rat forebrain and midbrain: A combined analysis by in situ hybridization and receptor autoradiography. J. Comp. Neurol. 341: 407-419.
45. ZSURGER, N., J. CHABRY, A. COQUEREL & J. P. VINCENT. 1992. Ontogenesis and binding properties of high-affinity neurotensin receptors in human brain. Brain 586: 303-310.
46. BOUDIN, H., A. GRUAZ-GUYON, M. P. FAURE, P. FORGEZ, A. M. LHIAUBET, M. DENNIS, A. BEAUDET, W. ROSTENE & D. PELAPRAT. 1995. Immunological recognition of different forms of the neurotensin receptor in transfected cells and rat brain. Biochem. J. 305: 277-283.
47. BOUDIN, H., D. PELAPRAT, W. ROSTENE & A. BEAUDET. 1996. Cellular distribution of the neurotensin receptor in rat brain: Immunohistochemical study using an antipeptide antibody against the cloned high-affinity receptor. J. Comp. Neurol. 373: 76-89.
48. MAZELLA, J., P. KITABGI & J. P. VINCENT. 1985. Molecular properties of neurotensin receptors in rat brain. J. Biol. Chem. 260: 508-514.
49. CHAKRAVARTY, P. K. & R. W. RANSOM. 1995. Neurotensin receptor antagonists. Curr. Pharm. Design 1: 317-324.
50. GULLY, D., M. CANTON, R. BOIGEGRAIN, F. JEANJEAN, J. C. MOLIMARD, M. PONCELET, C. GUEUDET, M. HEAULME, R. LEYRIS, A. BROUARD, D. PELAPRAT, C. LABBE-JULLIE, J. MAZELLA, P. SOUBRIE, J. P. MAFFRAND, W. ROSTENE, P. KITABGI & G. LE FUR. 1993. Biochemical and pharmacological profile of a potent and selective non-peptide antagonist of neurotensin receptor. Proc. Natl. Acad. Sci. USA 90: 65-69.
51. MAFFRAND, J. P., D. GULLY, R. BOIGEGRAIN, P. SOUBRIE, P. KITABGI, W. ROSTENE & G. LE FUR. 1993. Neurotensin receptor agonists and antagonists. Drugs of the Future 18(12): 1137-1141.
52. AZZI, M., D. GULLY, M. HEAULME, A. BEROD, D. PELAPRAT, P. KITABGI, R. BOIGEGRAIN, J. P. MAFFRAND, G. LE FUR & W. ROSTENE. 1994. Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists. Eur. J. Pharmacol. 255: 167-174.
53. 3H]dopamine release in rat striatal slices and mesencephalic cultures. Eur. J. Pharmacol. 253: 289-291.
54. BARKER, E. L., R. S. WESTPHAL, D. SMITH & E. SANDERS-BUSH. 1994. Constitutively active 5-hydroxytryptamine 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269: 11687-11690.
55. 3H SR 48692, in the guinea pig brain. J. Pharmacol. Exp. Ther. 273: 1450-1458.
56. BROUARD, A., D. PELAPRAT, C. DANA, M. VIAL, A. M. LHIAUBET & W. ROSTENE. 1992. Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors. J. Neurosci. 12: 1409-1415.
57. 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain. Proc. Natl. Acad. Sci. USA 83: 6203-6207.
58. SADOUL, J. L., F. CHECLER, P. KITABGI, W. ROSTENE, F. JAVOY-AGID & J. P. VINCENT. 1984. Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects. Biochem. Biophys. Res. Commun. 125: 395-404.
59. SZIGETHY, E. & A. BEAUDET. 1989. Correspondence between high affinity neurotensin binding site and dopaminergic neurons in the rat substantia and ventral tegmental area: A combined radioautographic and immunocytochemical light microscopic study. J. Comp. Neurol. 279: 128-137.
60. PONCELET, M., C. GUEUDET, D. GULLY, P. SOUBRIE & G. LE FUR. 1994. Turning behavior induced by intrastriatal injection of neurotensin in mice: Sensitivity to non peptide neurotensin antagonists. Naunyn-Schmiedebergs Arch. Pharmacol. 349: 57-60.
61. STEINBERG, R., P. BRUN, J. FOURNIER, J. SOUILHAC, D. RODIER, G. MONS, J. P. TERRANOVA, G. LE FUR & P. SOUBRIE. 1994. SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 59: 921-929.
62. STOESSL, A. J. 1995. Effects of neurotensin in a rodent model of tardive dyskinesia. Neuropharmacology 34: 457-462.
63. WAGSTAFF, J. D., L. G. BUSH, J. W. GIBB & G. R. HANSON. 1994. Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res. 665: 237-244.
64. PUGSLEY, T. A., H. C. AKUNNE, S. Z. WHETZEL, S. DEMATTOS, A. E. CORBIN, J. N. WILEY, D. J. WUSTROW, L. D. WISE & T. G. HEFFNER. 1995. Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonists. Peptides 16: 37-44.
65. URBAN, M. O. & D. J. SMITH. 1994. Localization of the antinociceptive and antianalgesic effect of neurotensin within the rostral ventromedial medulla. Neurosci. Lett. 174: 21-25.
66. URBAN, M. O., D. J. SMITH & R.C. BYRD. 1994. The non-peptide antagonist, SR 48692, reveals the antianalgesic action of neurotensin neuronal projections from the PAG to the RMg. Can. J. Physiol. Pharmacol. 72(Suppl. 1): 414.
67. PONCELET, M., J. SOUILHAC, C. GUEUDET, J. P. TERRANOVA, D. GULLY, G. LE FUR & P. SOUBRIE. 1994. Effects of SR 48692, a selective non peptide neurotensin receptor antagonist, on two dopamine-dependent behavioural responses in mice and rats. Psychopharmacology 116: 237-241.
68. BRUN, P., R. STEINBERG, G. LE FUR & P. SOUBRIE. 1995. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens. J. Neurochem. 64: 2073-2079.
69. LABBE-JULLIE, C., I. DUBUC, A. BROUARD, S. DOULUT, E. BOURDEL, D. PELAPRAT, J. MAZELLA, J. MARTINEZ, W. ROSTENE, J. COSTENTIN & P. KITABGI. 1994. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J. Pharmacol. Exp. Ther. 268: 328-336.
70. AL-RODHAN, N. R. F., E. RICHELSON, J. A. GILBERT, D. J. MCCORMICK, K. S. KANBA, M. A. PFENNING, E. W. LARSON & T. L. YAKSH. 1991. Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res. 557: 227-235.
71. LE, F., B. CUSACK & E. RICHELSON. 1996. The neurotensin receptor: Is there more than one subtype? TIPS 17: 1-3.
72. 3H SR 48692, the first nonpeptide neurotensin antagonist radioligand: Characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor. Mol. Pharmacol. 47: 1050-1056.
73. AZZI, M., A. NICOT, D. GULLY, P. KITABGI, A. BEROD & W. ROSTENE. 1994. Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692. Neurosci. Lett. 172: 97-100.
74. CREESE, I. & D. P. SIBLEY. 1981. Receptor adaptations to centrally acting drugs. Annu. Rev. Pharmacol. Toxicol. 21: 357-391.
75. WOULFE, J. & A. BEAUDET. 1989. Immunocytochemical evidence for direct connections between neurotensin-containing axons and dopaminergic neurons in the rat ventral midbrain tegmentum. Brain Res. 479: 402-406.
76. AZZI, M., H. BOUDIN, N. MAHMUDI, D. PELAPRAT, W. ROSTENE & A. BEROD. 1996. In vivo regulation of neurotensin receptors following long-term pharmacological blockade with a specific receptor antagonist. Mol. Brain Res. 42: 213-221.
77. MENDEZ, M., F. SOUAZE, M. NAGANO, P. A. KELLY, W. ROSTENE & P. FORGEZ. 1996. In vivo differential regulation of neurotensin receptor mRNA expression by SR48692 in rat brain and peripheral tissues. Soc. Neurosci. 22: Abstr. 515.3.
78. FAURE, M. P., A. ALONSO, D. NOUEL, G. GAUDRIAULT, M. DENNIS, J. P. VINCENT & A. BEAUDET. 1995. Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain. J. Neurosci. 15: 4140-4147.
79. MAZELLA, J., K. LEONARD, J. CHABRY, P. KITABGI, J. P. VINCENT & A. BEAUDET. 1991. Binding and internalization of iodinated neurotensin in neuronal cultures from embryonic mouse brain. Brain Res. 564: 249-255.
80. VANISBERG, M. A., J. M. MALOTEAUX, J. N. OCTAVE & P. M. LADURON. 1991. Rapid agonist-induced decrease of neurotensin receptors from the cell surface in rat cultured neurons. Biochem. Pharmacol. 42: 2265-2274.
81. 8] neurotensin (8-13). J. Pharmacol. Exp. Ther. 264: 1-5.
82. GOLDSTEIN, A., L. ARONOW & S. M. KALMAN. 1974. Consequences of drug-receptor interactions: Analysis of the graded dose-response relationship. In Principles of Drug Action: The Basis of Pharmacology, 2nd edit.: 82-111. Wiley. New York.
83. ROSTENE, W. & G. LE FUR. 1995. Peptide receptor antagonists. In Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990s. A. C. Cuello & B. Collier, Eds.: 29-36. Birkhäuser Verlag. Basel.